Fenozolone: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Protected "Fenozolone": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 44: | Line 44: | ||
}} | }} | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Fenozolone''' ('''Ordinator''') was developed by Laboratoires Dausse in the 1960s<ref>DE Patent 1297108B - 5-phenyl-2-ethylamino-4-oxazolinone and its preparation</ref> and is a [[psychoactive drug]] and [[stimulant]] related to [[pemoline]] and [[4-methylaminorex]] which acts as a [[releasing agent|norepinephrine-dopamine releasing agent]] (NDRA).<ref name="pmid6121837">{{cite journal | author = Gielsdorf W | title = Determination of the psychostimulants pemoline, fenozolone and thozalinone in human urine by gas chromatography/mass spectrometry and thin layer chromatography | journal = [[Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie]] | volume = 20 | issue = 2 | pages = 65–8 |date=February 1982 | pmid = 6121837 | doi = | url = | accessdate = 2009-08-03}}</ref> | '''Fenozolone''' ('''Ordinator''') was developed by Laboratoires Dausse in the 1960s<ref>DE Patent 1297108B - 5-phenyl-2-ethylamino-4-oxazolinone and its preparation</ref> and is a [[psychoactive drug]] and [[stimulant]] related to [[pemoline]] and [[4-methylaminorex]] which acts as a [[releasing agent|norepinephrine-dopamine releasing agent]] (NDRA).<ref name="pmid6121837">{{cite journal | author = Gielsdorf W | title = Determination of the psychostimulants pemoline, fenozolone and thozalinone in human urine by gas chromatography/mass spectrometry and thin layer chromatography | journal = [[Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie]] | volume = 20 | issue = 2 | pages = 65–8 |date=February 1982 | pmid = 6121837 | doi = | url = | accessdate = 2009-08-03}}</ref> | ||
==See also== | ==See also== | ||
* [[Aminorex]] | * [[Aminorex]] | ||
* [[Clominorex]] | * [[Clominorex]] | ||
* [[Fluminorex]] | * [[Fluminorex]] | ||
* [[Pemoline]] | * [[Pemoline]] | ||
| Line 65: | Line 60: | ||
{{Stimulants}} | {{Stimulants}} | ||
[[Category:Stimulants]] | [[Category:Stimulants]] | ||
[[Category:Lactams]] | [[Category:Lactams]] | ||
[[Category:Amines]] | [[Category:Amines]] | ||
[[Category:Drug]] | [[Category:Drug]] | ||
Latest revision as of 20:52, 18 August 2015
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C11H12N2O2 |
| Molar mass | 204.225 g/mol |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
|
WikiDoc Resources for Fenozolone |
|
Articles |
|---|
|
Most recent articles on Fenozolone |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Fenozolone at Clinical Trials.gov Clinical Trials on Fenozolone at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Fenozolone
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Fenozolone Discussion groups on Fenozolone Patient Handouts on Fenozolone Directions to Hospitals Treating Fenozolone Risk calculators and risk factors for Fenozolone
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Fenozolone |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Fenozolone (Ordinator) was developed by Laboratoires Dausse in the 1960s[1] and is a psychoactive drug and stimulant related to pemoline and 4-methylaminorex which acts as a norepinephrine-dopamine releasing agent (NDRA).[2]
See also
References
- ↑ DE Patent 1297108B - 5-phenyl-2-ethylamino-4-oxazolinone and its preparation
- ↑ Gielsdorf W (February 1982). "Determination of the psychostimulants pemoline, fenozolone and thozalinone in human urine by gas chromatography/mass spectrometry and thin layer chromatography". Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie. 20 (2): 65–8. PMID 6121837.
|access-date=requires|url=(help)
Categories:
- Pages with script errors
- Pages using citations with accessdate and no URL
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles with non-default infobox title
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Stimulants
- Lactams
- Amines
- Drug